Back to STATE STREET CORP STATE STREET CORP

DNTHDNTH
Showing 8 of 10 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in Dianthus Therapeutics, Inc.

STATE STREET CORP holds 2.4M shares of DNTH (Dianthus Therapeutics, Inc.), worth $229.8M as of 2026-Q2. The position was increased (+68.5% shares). DNTH represents 0.0% of STATE STREET CORP's portfolio.

Current Value

$229.8M

Current Shares

2.4M

Total Value Change

+$207.3M

Total Shares Change

+1.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.4M
+68.5%
$229.8M0.0%$97.48
45
2026-Q1
Decreased
1.4M
-7.2%
$117.4M0.0%$55.39
0
2025-Q4
Increased
1.5M
+124.7%
$62.1M0.0%$40.96
48
2025-Q3
Decreased
671,048
-18.2%
$26.4M0.0%$39.55
0
2025-Q2
Increased
820,137
+8.0%
$15.3M0.0%$17.63
30
2025-Q1
Decreased
759,679
-7.2%
$13.8M0.0%$19.99
0
2024-Q4
Decreased
818,843
-0.3%
$17.9M0.0%$21.50
0
2024-Q3
Increased
821,131
+101.4%
$22.5M0.0%$27.24
46

Other major holders of DNTH: FMR LLC, BlackRock, Inc., WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used